Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$1.84 - $6.44 $322,000 - $1.13 Million
-175,000 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$1.54 - $6.75 $269,500 - $1.18 Million
175,000 New
175,000 $383,000
Q3 2019

Nov 12, 2019

SELL
$3.04 - $4.91 $76,000 - $122,750
-25,000 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$3.72 - $6.95 $93,000 - $173,750
25,000 New
25,000 $105,000

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $245M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.